retatrutide type 2 diabetes phase 2 trial hba1c π©Ί in diabetes: TRANSCEND-T2D-1 3 results β β2.0% + weight β16.8% at 40 weeks. A triple agonist that tackles both glycemia and obesity simultaneously. ππ Ref: Lilly ADA 2026: Retatrutide Revolution
Pay in 4 interest-free payments of $7.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 18 - Aug 23






















:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)




